Sinclair ready to launch Silhouette InstaLift in the US through distributor ThermiGen
Sinclair Pharma is to launch its facelift product, Silhouette InstaLift, in the US through distributor ThermiGen. US approval is also underway for a second product. The company has recently expanded into Brazil, the second largest global market for cosmetic products. Sales in 2016 are predicted to grow 40%. In 2015, Sinclair carried out major destocking and divestment of the majority of its products, in addition to changing its year-end accounting period.

The US is a massive market for cosmetic enhancement products, which no doubt explains the move by Sinclair Pharma (SPH) to launch stateside. Its facelift product, Silhouette InstaLift, is being sold via distributors ThermiGen, and though it is only early days, demand is already growing.

IC TIP: Buy at 29p

US expansion is not all that's new about Sinclair in this reported period which, due to a change in the year-end, is a second interim period in a new financial year to December 2016. In late 2015, the group underwent a major destocking to reduce the lumpy nature of sales to large European customers, which has helped reign in costs. Although sales are flat compared with the six months to June 2015, chief executive Chris Spooner argues these numbers are a much better reflection of the actual market demand, and the company has bounced back from a revenue dip in the six months to December 2015 as customers adjusted to the changes.